← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2007Last known activity
Feb 28, 2026
Timeline
1990s
- Jun 1, 1997
Xencor— Founded
Drugs by trial phase (27 distinct, 32 trials)
Phase 2 (15 own, 0 via acquisition)
Indications
Studied for
- Anus Neoplasms
- Basal Cell Carcinoma
- Blast Crisis
- Breast Neoplasms
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Colorectal Neoplasms
- Conjunctivitis
- Conjunctivitis, Allergic
- Dermatitis
- Dermatitis, Atopic
- Digestive System Neoplasms
- Eczema
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Neoplasms
- Histiocytoma, Malignant Fibrous
- Hodgkin Disease
- Immunoglobulin G4-Related Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- Melanoma
- Mesothelioma
- Nasopharyngeal Carcinoma
- Neuroendocrine Tumors
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rhinitis
- Rhinitis, Allergic
- Sarcoma
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Thymoma
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
- Vulvar Neoplasms
Recent trials (46)
- NCT07284797OfficialPhase 1Feb 28, 2026
- NCT07284797Lead sponsorPhase 1Feb 28, 2026
- NCT07230353OfficialPhase 1Oct 21, 2025
- NCT07230353Lead sponsorPhase 1Oct 21, 2025
- NCT05900648CollaboratorPhase 2Nov 30, 2024
- NCT06619990CollaboratorPhase 1/Phase 2Oct 10, 2024
- NCT06276491Lead sponsorPhase 1Apr 4, 2024
- NCT06173505Lead sponsorPhase 1/Phase 2Dec 31, 2023
- NCT05733351CollaboratorPhase 1Aug 3, 2023
- NCT05996445Lead sponsorPhase 1Jul 28, 2023
- NCT05879185CollaboratorPhase 2Apr 6, 2023
- NCT05695898CollaboratorPhase 1/Phase 2Feb 28, 2023
- NCT05585034Study directorPhase 1Nov 30, 2022
- NCT05585034Lead sponsorPhase 1Nov 30, 2022
- NCT06005792Lead sponsorPhase 1Oct 10, 2022
Details
- Founded
- Monrovia, CA, US Jun 1, 1997
- Last known activity
- Feb 28, 2026